# Evaro

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/evaro

- Industry: Healthcare IT
- Headquarters: Norwich, UK
- Website: www.evaro.com
- Total disclosed funding: $26M
- Latest round: Series A (Jan 27, 2026)
- Investors on record: 9

## About

Established in 2017 and based in Norwich, UK, Total Access Health Ltd., dba Evaro, operates as a healthcare technology company that offers digital health solutions and healthcare accessibility. Thuria Wenbar (CEO) and Oskar Wendowski (CPO) are the co-founders of the company. In January 2026, Evaro raised GBP 18 million in series A funding led by Albion Capital, BBI, Exceptional Ventures, Simplyhealth Ventures, and Cornerstone VC. Evaro generates revenue through a B2B pharmaceutical infrastructure-as-a-service model, enabling consumer brands to integrate prescription medication services seamlessly into their offerings. The company will use the January 2026 funding to scale its digital pharmacy infrastructure and expand regulated online care services with partners.

## Funding rounds

- Series A, Jan 27, 2026, $24M — Albion Capital, Exceptional Ventures, Simplyhealth Ventures, Cornerstone VC, BBI
- Seed, Jan 26, 2023, $1.4M — SyndicateRoom, University of East Anglia, Exceptional Ventures, Cornerstone, Calisi's Investment Arm

## Investors

- SyndicateRoom (https://capitalatlas.ai/funds/syndicateroom) — Seed
- University of East Anglia — Seed
- Exceptional Ventures (https://capitalatlas.ai/funds/exceptional-ventures) — Seed, Series A
- Cornerstone — Seed
- Calisi's Investment Arm — Seed
- Albion Capital — Series A
- Simplyhealth Ventures (https://capitalatlas.ai/funds/simplyhealth-ventures) — Series A
- Cornerstone VC (https://capitalatlas.ai/funds/cornerstone-vc) — Series A
- BBI — Series A